JohnAnilLincolnMDPhD

PubMed

• Glymphatic dysfunction in multiple sclerosis and its association with disease pathology and disability.
  Ahmed Bayoumi, Khader M Hasan, Joseph A Thomas, Akram Yazdani, John A Lincoln
  Multiple Sclerosis. 2024-11-01
• Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.
  Benjamin C Musall, Refaat E Gabr, Yanyu Yang, Arash Kamali, John A Lincoln
  Scientific Reports. 2024-07-26
• 1 citations
  Voiding Phase Dysfunction in Multiple Sclerosis: Contemporary Review of Terminology, Diagnosis, Management, and Future Directions.
  Catherine Frances Ingram, John A Lincoln, Rose Khavari
  The Urologic Clinics of North America. 2024-05-01

Journal Articles

• Interleaved Susceptibility-Weighted and FLAIR MRI for Imaging Lesion Penetrating Veins in Multiple Sclerosis  
  Gabr RE, Pednekar AS, Kamali A, Lincoln JA, Nelson FM, Wolinsky JS, Narayana PA, Magnetic Resonance Medicine, 1/1/2017
• Brain Lesions: To Biopsy or Not To Biopsy A Single Institution Experience  
  Aisenberg GM, Lincoln JA, Lincoln CM, Fenoy AJ, Benjamin-Garner RA, J Neuroscience & Clinical Research, 1/1/2016
• Antivirus immune activity in multiple sclerosis correlates with MRI activity  
  Latham LB, Lee MJ, Lincoln JA, Ji N, Forsthuber TG, Lindsey JW, Acta Neurol Scand, 1/1/2015
• Multiple Sclerosis Mimics: Case Presentations  
  Lincoln JA, Texas Neurological Society: Broca’s Area, Winter, 1/1/2015
• ABPN Self-Assessment Cases in Multiple Sclerosis for Maintenance of Certification  
  Lincoln JA, Neurology Reviews, 1/1/2010
• Join now to see all

Books/Book Chapters

• Nanomedicine for Inflammatory Diseases: A Translational Medicine Book. 
  Chapter: The Biology and Clinical Treatment of Multiple Sclerosis. 
  Page 171 - 192Khayat-Khoei M, Freeman L and Lincoln JEditors: L. Milane and M. Amiji.CRC Press/Taylor and Francis2017
• Reference Module in Biomedical Sciences. 
  Chapter: The Role of Interferons on the Central Nervous System in Health and Disease. 
  Dafny N and Lincoln JElsevier2016
• Wearable Robotics: Challenges and Trends. 
  Chapter: Wearable Exoskeleton Assisted Rehabilitation in Multiple Sclerosis: Feasibility and Experience. 
  Page 15 - 19Chang SH, Kern M, Afzal T, Tseng SC, Lincoln J, Francisco GEditors: J Gonzalez-Vargas.Springer International Publishing2016
• AIDS, Drugs of Abuse, and the Neuroimmune Axis. 
  Chapter: Alteration of Macrophage Functions by Cocaine. 
  Page 135 - 144Lefkowitz SS, Vaz A, Lincoln JA, Cain T, Brown D, Lefkowitz DLEditors: H. Friedman.Plenum Press, New York, NY1996
• Join now to see all

Abstracts/Posters

• Radiomic Prediction of Clinical Outcome in Multiple Sclerosis Patients from the CombiRx Cohort. P135.
  K Wahid, A Kotrotsou, R Colen, S Cofield, G Cutter, J Lincoln, F Lublin, P Narayana, J Wolinsky, L Freeman, ACTRIMS, San Diego, CA, 1/1/2018
• Exploring the Relationship between Endothelin-1 and Peripheral Inflammation in Multiple Sclerosis. P003.
  J Bravo-Alegria, G Colpo, J Lincoln, J Lindsey, N Rocha, A Teixeira, J Wolinsky, L Freeman, ACTRIMS, San Diego, CA, 1/1/2018
• Novel Multi-band accelerated, Reference-less, Multifaceted Icosahedral and Multishell Diffusion MRI Protocol for human whole brain clinical applications.
  KM Hasan, RE Gabr, JA Lincoln, PA Narayana, ISMRMESMRMB, Paris, France, 1/1/2018
• Micro and Macrostructural Limbic System Correlates of Comprehensive Cognitive Symptomatology in Multiple Sclerosis using Quantitative MRI and DTI. P358.
  Z Keser, J Lincoln, F Nelson, K Hasan, AAN, Los Angeles, CA, 1/1/2018
• A Report of Seronegative Neuromyelitis Optica (NMO) in the Setting of Acute HIV Infection. P1113.
  M Khayatkhoei, J Lincoln, AAN, Los Angeles, CA, 1/1/2018
• Enhanced Regional Cerebral Perfusion Following Acetazolamide: Preliminary Results.
  JA Lincoln, L Freeman, L Staine, KM Hasan, R Gabr, PA Narayana, JS Wolinsky, ECTRIMS, Paris, France, 1/1/2017
• Grey matter hypoperfusion and subsequent brain atrophy in MS.
  L Freeman, JA Lincoln, PA Narayana, JS Wolinsky, ACTRIMS, Orlando, FL, 1/1/2017
• Can Improving Cerebral Perfusion Impact the Evolution of Multiple Sclerosis Lesions?
  JA Lincoln, L Freeman, R Gabr, K Hasan, PA Narayana, JS Wolinsky, ACTRIMS, Orlando, FL, 1/1/2017
• Toward Real Time Estimation and Quality Assurance for Myelin Water Mapping in the Human CNS.
  Khader M Hasan, Refaat E Gabr, John A Lincoln, and Ponnada A Narayana, ISMRM, Honolulu, HI, 1/1/2017
• Improving white matter lesion conspicuity in multiple sclerosis using patient-specific optimization of 3D FLAIR.
  Refaat E Gabr, Amol S Pednekar, Koushik A Govindarajan, Xiaojun Sun, Roy F Riascos, María G Ramírez, Khader M Hasan, John A Lincoln, Flavia M Nelson, Jerry S Wolinsky,..., ISMRM, Honolulu, HI, 1/1/2017
• Evaluation of Quality of Life Measures for Wearable Robotic Therapy in Individuals with Neurological Disability: A Preliminary Report.
  Julia Poritz, Laurel Patterson, Shih-Chiao Tseng, John Lincoln and ShuoHsiu Chang, WeRob, Houston, TX, 1/1/2017
• Pediatric Onset Multiple Sclerosis: Evaluation of Sequential Brain MR Imaging to Study the Disease Evolution and Predict Outcomes.
  K Jobanputra, F Nelson, J Lincoln, A Kamali, R Patel, ASNR, Long Beach, CA, 1/1/2017
• Grey matter hypoperfusion and subsequent brain atrophy in MS: a longitudinal MRI study with pseudo-continuous arterial spin labeling.
  L. Freeman, J.A. Lincoln, P.A. Narayana, J.S. Wolinsky, ECTRIMS, London, United Kingdom, 1/1/2016
• Metabolic expenditures during exoskeleton-assisted walking in person with multiple sclerosis.
  Afzal T, Kern M, Tseng S, Lincoln J, Chang S, American Association of Psychiatry, Sacramento, CA, 1/1/2016
• A Case of Sporadic Variant of Creutzfeldt-Jakob Disease.
  J.K. Randhawa, A. Pemberton, S. Chandra, P. Datta, J.A. Lincoln, P.E. Schulz, Texas Neurological Society, Austin, TX, 1/1/2016
• Evidence of widespread cortical hypoperfusion in MS: a surface-based MRI study with pseudocontinuous arterial spin labeling.
  Freeman L, Lincoln J, Narayana P, Wolinsky J, ECTRIMS, Late Breaking News, Barcelona, Spain, 1/1/2015
• Predicting Confirmed Disability Progression in MS: Importance of Early on Treatment MRI Changes on Modeling the CombiRx Trial Database.
  F Lalys, L Freeman, J Lincoln, F Nelson, P Narayana, S Cofield, T Gustafson, G Cutter, F Lublin, J Wolinsky, AAN, Philadelphia, PA, 1/1/2014
• Early on-treatment T2 and T1 subtraction MRI predicts imaging and clinical outcomes in the CombiRx cohort.
  L Freeman, F Lalys, JA Lincoln, F Nelson, PA Narayana, S Cofield, T Gustafson, GR Cutter, FD Lublin, JS Wolinsky, ECTRIMS, Boston, MA, 1/1/2014
• Measures of Epstein-Barr virus activity correlate with enhancing lesions on MRI in multiple sclerosis.
  Lincoln JA, ECTRIMS, Copenhagen, Denmark, 1/1/2013
• Should MRI be used in addition to clinical criteria to classify and monitor the course of multiple sclerosis?
  Cook SD, Lincoln J, Cadavid D, 19th World Congress of Neurology, Bangkok, Thailand, 1/1/2009
• A Longitudinal Month by Month Preliminary Analysis of the Outcome of Black Holes in Patients with Multiple Sclerosis in the BECOME Study.
  Cheriyan J, Lincoln JA, Skurnick J, Cook SD, Wolansky L, Cadavid D, AAN, Washington, DC, 1/1/2007
• Betaseron vs. copaxone in MS with triple-dose gadolinium and 3-T MRI Endpoints (BECOME): Announcement of final primary study outcome.
  Wolansky L, Cook SD, Skurnick J, Lincoln JA, Franco P, Haghighi M, Peng B, Lebovitz Y, Petscavage J, Szczepanowski K, Cadavid D, ECTRIMS, Prague, Czech Republic, 1/1/2007
• Comparison of Betaseron and Copaxone on newly enhancing lesions by monthly 3T MRI with triple dose gadolinium: Secondary outcomes in a 15-month analysis of the BECOME ...
  Lincoln JA, Belenguer A, Vidgop E, Cadavid D, Wolansky L, Skurnick JH, Cook SD, AAN, Boston, MA, 1/1/2007
• Outcome of T1 Hypointensities in Patients with Early Forms of Multiple Sclerosis Randomized to Betaseron or Copaxone and Followed Prospectively by Monthly 3T MRI for u...
  Cadavid D, Lincoln J, Baguero A, Segal L, Gómez-Choco M, Alemani MJ, Peng B, Tullock K, Joseph G, Vidgop Y, Baladandapani P, Szczepanowski K, Skurnick J, Halper J, Coo..., ECTRIMS, Barcelona, Spain, 1/1/2006
• Myeloperoxidase Induces Astrocytes to Secrete Proinflammatory Cytokines.
  Stuart RW, Cain WC, Lincoln JA, Lefkowitz DL, Lefkowitz SS, Allen RC, ASMB/ASI/AAI Joint Meeting, San Francisco, CA, 1/1/1998
• Join now to see all

Lectures

• Switching and Escalating Therapies 
  Baylor College of Medicine - 1/1/2016
• What’s New in MS 
  Houston, TX - 1/1/2016
• Role of MRI in 2013 MS Phenotype 
  Indianapolis, IN - 1/1/2015
• Making an Accurate Diagnosis of Multiple Sclerosis: What Are the Mimics You Don't Want to Miss 
  Baylor College of Medicine - 1/6/2014
• Review of Clinical Classifications 
  Teaneck, NJ - 1/10/2012
• Update on New and Emerging Oral Therapies in Multiple Sclerosis 
  Houston, TX - 1/7/2012
• Overview Stroke Neurology 
  Strake Jesuit High School - 1/7/2012
• Clinical Pathology Case Conference 
  Richmond University Medical Center, Staten Island, NY - 1/28/2010
• Multiple Sclerosis: An Update on Diagnosis and Therapy 
  Mountainside Hospital, Montclair, NJ - 1/15/2010
• Overview of Dalfampridine Trials 
  Newark, NJ - 1/5/2010
• Immunology of Multiple Sclerosis: Nurses Symposium 
  University of Medicine & Dentistry of NJ, Newark, NJ - 1/1/2010
• Surrogate Markers in Multiple Sclerosis 
  UT Medical School, Houston, TX - 1/1/2010
• Immunology of Multiple Sclerosis 
  West Orange, NJ - 1/17/2008
• Join now to see all

Other

• Ph.D. Thesis: Regulation of the macrophage inflammatory response by eosinophil peroxidase. 
  Lincoln JA, SWC/SCL--University Archives
  Texas Tech University, Lubbock, TX - 1/1/1998
• M.S. Thesis: Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. 
  Lincoln JA
  http://hdl.handle.net/2346/12069
  Texas Tech University, Lubbock, TX - 1/1/1995
• The Role of MRI in MS Diagnosis and Management. 
  Nelson F and Lincoln J, Medscape Education – Neurology
  http://www.medscape.org/viewarticle/760543